Description: The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.
Home Page: www.direxioninvestments.com/products/daily-sp-biotech-bull-3x-shares
LABD Technical AnalysisExchange: NYSE ARCA
Country: US
Currency: US Dollar ($)
Category: Trading--Inverse Equity
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Cash | 90.18 | 0.00 | 90.18 |
| Other | 18.82 | 0.00 | 18.82 |
| Stock non-US | 0.00 | 9.00 | -9.00 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |